Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

SpaceX

SpaceX Raises $1.25B in Series Unknown

1 Rocket Road, Hawthorne, CA 90250June 7, 20242 min read
Employees
13000+

SpaceX Raises $1.25B in Series Unknown


SpaceX has successfully raised $1.25B in a Series Unknown at a $180B valuation led by Andreessen Horowitz, Sequoia Capital, Fidelity, Baillie Gifford, Valor Equity Partners, Gigafund.


Company Overview


SpaceX is a Aerospace company headquartered in 1 Rocket Road, Hawthorne, CA 90250, founded in 2002 with 13000+ employees.


Aerospace manufacturer and space transportation


Fundraising Details


  • Amount Raised: $1.25B
  • Round Type: Series Unknown
  • Valuation: $180B
  • Date: 2024-06-07
  • Investors: Andreessen Horowitz, Sequoia Capital, Fidelity, Baillie Gifford, Valor Equity Partners, Gigafund

About SpaceX


Aerospace manufacturer and space transportation The company is positioned in the Aerospace sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 1 Rocket Road, Hawthorne, CA 90250
  • Founded: 2002
  • Team Size: 13000+
  • Industry: Aerospace

What This Means


This funding round demonstrates strong investor confidence in SpaceX's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Aerospace sector continues to attract significant investment as companies innovate to meet evolving market demands. SpaceX's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $180B valuation marks an important milestone for SpaceX, positioning the company among notable players in the Aerospace industry.


Looking Ahead


With this new capital, SpaceX is well-positioned to execute on its growth strategy and continue building innovative solutions in the Aerospace space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-06-07. For more information about SpaceX, visit their headquarters at 1 Rocket Road, Hawthorne, CA 90250.

Company Info

Headquarters
1 Rocket Road, Hawthorne, CA 90250
Founded
2002
Team Size
13000+

Topics

Fundraising(2912)Aerospace(308)Series UnknownSpaceX

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free